EPAM vs XERS · P/E 14, rev $2.81B vs rev $175.2M
EPAM Systems Inc (EPAM) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. XERS currently screens at market cap $760.7M.
Not investment advice. Open the EPAM and XERS stock pages for the full models.
Not investment advice.